Effect of praziquantel administration on hepatic stereology of mice infected with Schistosoma mansoni and fed a low-protein diet

Braz J Med Biol Res, September 2009, Volume 42(9) 812-815 (Short Communication)

Effect of praziquantel administration on hepatic stereology of mice infected with Schistosoma mansoni and fed a low-protein diet

L.A. Barros^1,2, M. Costa-Silva¹, C.L. Biolchini¹, R.H. Neves² and J.R. Machado-Silva¹

¹Laboratório de Helmintologia Romero Lascasas Porto, Departamento de Microbiologia, Imunologia e Parasitologia, Faculdade de Ciências Médicas, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, RJ, Brasil

²Laboratório de Helmintos Parasitos de Vertebrados, Instituto Oswaldo Cruz, FIOCRUZ, Rio de Janeiro, RJ, Brasil

References

^{Correspondence and Footnotes}

Abstract

A study was undertaken to investigate the effect of administering praziquantel (PZQ), focusing on the liver stereological findings of malnourished mice infected with Schistosoma mansoni. Thirty female Swiss Webster mice (age: 21 days; weight: 8-14 g) were fed either a low-protein diet (8%) or standard chow (22% protein) for 15 days. Five mice in each group were infected with 50 cercariae each of the BH strain (Brazil). PZQ therapy (80 mg/kg body weight, per day) was started on the 50th day of infection and consisted of daily administration for 5 days. Volume density (hepatocytes, sinusoids and hepatic fibrosis) was determined by stereology using a light microscope. Body weight gain and total serum albumin levels were always lower in undernourished mice. Our stereological study demonstrated that treatment increased both volume density of hepatocytes in mice fed standard chow (47.56%, treated group and 12.06%, control) and low-protein chow (30.98%, treated group and 21.44%, control), and hepatic sinusoids [standard chow (12.52%, treated group and 9.06%, control), low-protein chow (14.42%, treated group and 8.46%, control)], while hepatic fibrosis was reduced [standard chow (39.92%, treated group and 78.88%, control) and low-protein chow (54.60%, treated group and 70.10%, control)]. On the other hand, mice fed low-protein chow decreased density volume of hepatocytes and hepatic fibrosis. In conclusion, our findings indicate that treatment with PZQ ameliorates hepatic schistosomiasis pathology even in mice fed a low-protein diet.

Key words: Schistosoma mansoni; Low-protein diet; Stereology; Praziquantel

Introduction

Over the last several years, experimental studies in mice have demonstrated that host nutritional status may influence the outcome and progression of schistosomiasis infection, since it interferes with the dynamics of connective tissue changes occurring in hepatic lesions (1). Undernourished mice exhibit diminished periovular granuloma and minimal liver fibrosis compared to control animals (2).

Chemotherapy with praziquantel (PZQ) plays a very important role in reducing the morbidity of Schistosoma mansoni-infected mice, effectively killing adult worms and mature eggs trapped in the host tissues (3). Additionally, it decreases inflammation and progressive matrix degradation (4). In contrast, protein-deficient mice cannot effectively clear adult worms after PZQ compared to nourished mice (5).

Although proved relevant in clinical studies (6), stereological data on parasitic infection are rather scarce (7). In a previous investigation, stereology also proved to be useful for experimental evaluation of the nutritional effects of a high-fat diet in murine schistosomiasis (8). On the basis of the considerations, the objective of the present study was to test liver status following PZQ administration to S. mansoni-infected mice fed a low-protein diet, using stereology parameters.

Material and Methods

Animals

Thirty female Swiss Webster mice (age: 21 days; weight: 8-14 g) were obtained from The FIOCRUZ Central Animal House breeding stock (Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil). The animals were housed under standard caging conditions, i.e., temperature of 21 ± 1°C, 60 ± 10% humidity, a 12-h light and dark cycle, and permitted ad libitum consumption of water and pellet chow. All animal experiments were conducted in accordance with valid international guidelines for animal experimentation.

Diets. After weaning, experimental mice were fed a low-protein diet with an 8% protein content and standard chow mice were fed a normal chow (Nuvilab®, Brazil) with a 22% protein content throughout the investigation.

Nutritional status evaluation. Body weight was measured twice a week throughout the experiment and serum albumin concentration was measured after 15 days of the low-protein diet.

Infection. Mice were exposed subcutaneously to ~50 S. mansoni cercariae (BH strain, Brazil) 15 days after ingesting their respective diets. The cercariae were obtained from laboratory-raised and -infected Biomphalaria glabrata, as described (8).

Treatment. PZQ (80 mg/kg; Merck, Germany) was orally administered to mice by stomach gavage in 2% Cremophor EL (Sigma, USA) for 5 consecutive days, beginning on day 50 after infection.

Experimental groups. S. mansoni-infected mice were allocated to six groups of 5 mice each, as follows: group I (IUSC): infected untreated mice fed a standard chow. Group II (IULC): infected untreated mice fed a low-protein chow. Group III (ITSC): infected treated mice fed a standard chow. Group IV (ITLC): infected treated mice fed a low-protein chow. Group V (USC): uninfected mice fed a standard chow. Group VI (ULC): uninfected mice fed a low-protein chow.

Autopsy. Seventeen days after the last PZQ administration, all mice were euthanized by cervical dislocation. A midline incision was made in the thorax and abdomen of the mice to remove the liver.

Tissue processing. Liver volume was measured by the immersion method (9). Livers were fixed in freshly prepared 4% formaldehyde, w/v, in 0.1 M phosphate buffer, pH 7.2, and embedded in paraffin. Histologic sections (5 µm) were obtained and stained with Masson's trichrome.

Stereological study

The liver was analyzed considering hepatocytes, sinusoids, and hepatic fibrosis. Details of the procedures are given elsewhere (8). Briefly, hepatic fragments (minimum of three fragments per animal) were embedded together and oriented to provide a random cut when sectioned. Several sections were cut and five microscopic fields were randomly analyzed using a video-microscopic system (Olympus BX 50, Japan) and a test system consisting of 42 points (PT), i.e., volume density of hepatocytes (Vv [h]), sinusoids

(Vv [s]) and hepatic fibrosis (Vv [hf]), was determined as follows: Vv = PP / PT (%), where PP represents the points hitting the structures (10).

Statistical analysis

Data analysis was performed using the Statistical Package for the Social Sciences (SPSS) version 9.0. Data are reported as means ± SD and were analyzed by the Mann-Whitney test and/or the Kruskal-Wallis test followed by post-test to determine which groups were divergent. The level of significance was set at P < 0.05.

Results

Animal biometry and nutritional data

Body weight gain and total serum albumin levels were lower (P < 0.05) in the mice fed the low-protein diet compared to well-nourished mice (Table 1).

The liver weight ratios of malnourished mice (IULC and ITLC) were always lower than those of their counterparts (well-fed mice - IUSC and ITSC). Liver weight after PZQ therapy was significantly (P < 0.05) lower in the ITLC group than in well-fed mice (Table 1).

Stereological study

Table 2 presents the stereological findings.

Hepatocytes. The volume density of hepatocytes was larger in animals fed the standard diet compared to mice fed the low-protein diet: 81.18% (USC) and 71.70% (ULC). Our stereological study demonstrated that treatment increased the percentage of hepatocytes in mice fed the standard chow (47.56%) compared to mice fed the low-protein chow (30.98%). IUSC, IULC, ITSC, and ITLC values differed significantly (P < 0.05) from control (USC and ULC).

Sinusoids. The volume density of sinusoids differed (P = 0.001) between uninfected mice [18.82% (USC), 28.36% (ULC)], infected mice [9.06% (IUSC), 8.46% (IULC)], and treated mice [12.52% (ITSC), 14.42% (ITLC)]. However, no significant difference (P > 0.05) was observed between IULC vs IUSC and ITSC vs ITLC groups.

Hepatic fibrosis. Mice fed the low-protein chow showed a decreasing percentage of hepatic fibrosis: 78.88% (IUSC), 70.10% (IULC). The volume density of hepatic fibrosis was significantly different (P = 0.001) between IUSC vs IULC and ITSC vs ITLC groups.

Table 1.
Biochemical and biometrical characteristics of schistosomiasis-infected Swiss Webster mice fed low-protein or standard chow and treated or not with praziquantel.

Table 2.
Stereological densities of hepatocytes, sinusoids and hepatic fibrosis in schistosomiasis-infected Swiss Webster mice fed low-protein or standard chow and treated or not with praziquantel.

Discussion

Experimental models have been extensively used to assess the effects of nutritional status on schistosomiasis mansoni infection (11,12). Previous research has shown that feeding a low-protein diet leads to a reduction in total body weight gain and serum albumin levels in mice infected with S. mansoni (13). Indeed, we have found that feeding mice a low-protein diet induces malnutrition. One explanation for this effect may lie in some liver-specific proteins like albumin that are known to respond to dietary management, such as protein malnutrition, by reducing hepatic protein synthesis (14).

Although proved relevant in clinical studies (6), very little is known about stereological data in hepatic schistosomiasis (7,8). The diet of the host has been suggested to be a stimulation factor to hepatic regeneration (15). Schistosomiasis also represents a stimulus during the acute phase of the infection (8,15). The present findings showed that both malnutrition and schistosomiasis led to adverse effects on liver morphology. The volume density of hepatocytes was smaller in uninfected mice fed low-protein chow than in those fed a 22% protein diet.

Granuloma formation in schistosomiasis is a manifestation of delayed-type hypersensitivity to antigenic material released by S. mansoni eggs that peaks at 8 weeks post-infection (16). Liver fibrosis is a complex process resulting from increased synthesis and deposition of extracellular matrix components (17). Histopathological and morphometric data indicate that undernourished mice develop smaller circumoval granulomas, less intense portal inflammation, and minimal liver fibrosis when compared with control animals. Additionally, decreased total liver fibrosis may have resulted from an impaired mechanism of repair, a lower antigen load or a low antibody production due to a low protein content (2). In the present study, Vv fibrosis was not statistically different between the groups of infected mice. However, in contrast to the present study, undernourished mice failed to develop liver fibrosis as extensively as well-nourished mice (1,11).

PZQ chemotherapy eliminates parasites and kills mature eggs trapped in the host tissues (3). However, there are no reports so far of its efficacy in malnourished hosts. Results from the present study provide additional strong evidence for the beneficial effects of praziquantel. The liver responds to injury with regulated tissue regeneration every time there is a major loss of hepatic tissue (18). Treatment reduces the morbidity of S. mansoni-infected mice because periovular granulomas very rapidly regress in size after reduction of the amount of collagen (4,19).

Our stereological study demonstrated that Vv hepatocytes and Vv sinusoids were significantly increased, whereas Vv fibrosis was reduced after chemotherapy. It is clear that Vv fibrosis reduction was larger in the well-fed than in the low-protein-fed infected mice. This result seems to contradict other studies demonstrating that malnourished infected mice present a lower inflammatory response than well-fed mice (2). Our findings confirm studies demonstrating that protein deficiency impairs the schistosomicidal action of PZQ (5). Based on stereology, our findings indicate that treatment with PZQ ameliorates the hepatic disease caused by schistosomiasis in mice fed a low-protein diet.

Acknowledgments

We wish to thank Dr. Carlos Alberto Mandarim-de-Lacerda from Laboratório de Morfologia e Morfometria Cardiovascular, Instituto de Biologia Roberto Alcantara Gomes, Cento Biomédico, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, for critical comments.

Address for correspondence: J.R. Machado-Silva, Laboratório de Helmintologia Romero Lascasas Porto, Departamento de Microbiologia, Imunologia e Parasitologia, Faculdade de Ciências Médicas, UERJ, Av. Prof. Manuel de Abreu, 444, 20551-170 Rio de Janeiro, RJ, Brasil. Fax: [phone]. E-mail: [e-mail]

Research partially supported by CNPq and FAPERJ (Carlos Chagas Filho Research Support Foundation of the State of Rio de Janeiro). J.R. Machado-Silva is the recipient of a Productivity fellowship from CNPq. Received September 29, 2008. Accepted June 22, 2009.

The Brazilian Journal of Medical and Biological Research is partially financed by

References

• 1. Coutinho EM, Silva FL, Barros AF, Araujo RE, Oliveira SA, Luna CF, et al. Repeated infections with Schistosoma mansoni and liver fibrosis in undernourished mice. Acta Trop 2007; 101: 15-24.
• 2. Coutinho EM. Malnutrition and hepatic fibrosis in murine schistosomiasis. Mem Inst Oswaldo Cruz 2004; 99: 85-92.
• 3. Giboda M, Smith JM. Schistosoma mansoni eggs as a target for praziquantel: efficacy of oral application in mice. J Trop Med Hyg 1994; 97: 98-102.
• 4. Andrade ZA, Cox TM, Cheever AM. Regression of hepatic lesions after treatment of Schistosoma mansoni or Schistosoma japonicum infection in mice: a comparative study. Am J Trop Med Hyg 1993; 49: 1-9.
• 5. Lima SF, Souza CT, Vieira LQ, Coelho PM. Protein deficiency impairs the schistosomicidal action of praziquantel. Mem Inst Oswaldo Cruz 1998; 93 (Suppl 1): 271-272.
• 6. Lazzarini AL, Levine RA, Ploutz-Snyder RJ, Sanderson SO. Advances in digital quantification technique enhance discrimination between mild and advanced liver fibrosis in chronic hepatitis C. Liver Int 2005; 25: 1142-1149.
• 7. Friis H, Andersen CB, Vennervald BJ, Christensen NO, Pakkenberg B. The use of a stereological method to estimate the volume of Schistosoma mansoni granulomas: the effect of zinc deficiency. Ann Trop Med Parasitol 1998; 92: 785-792.
• 8. Neves RH, Alencar AC, Aguila MB, Mandarim-de-Lacerda CA, Machado-Silva JR, Gomes DC. Hepatic stereology of schistosomiasis mansoni infected-mice fed a high-fat diet. Mem Inst Oswaldo Cruz 2006; 101 (Suppl 1): 253-260.
• 9. Scherle W. A simple method for volumetry of organs in quantitative stereology. Mikroskopie 1970; 26: 57-60.
• 10. Mandarim-de-Lacerda CA. Stereological tools in biomedical research. An Acad Bras Cienc 2003; 75: 469-486.
• 11. Coutinho EM, de Souza MM, Silva LM, Cavalcanti CL, de Araujo RE, Barbosa Junior AA, et al. Pathogenesis of schistosomal 'pipestem' fibrosis: a low-protein diet inhibits the development of 'pipestem' fibrosis in mice. Int J Exp Pathol 1997; 78: 337-342.
• 12. Neves RH, Miranda de Barros Alencar AC, Costa-Silva M, Aguila MB, Mandarim-de-Lacerda CA, Machado-Silva JR, et al. Long-term feeding a high-fat diet causes histological and parasitological effects on murine schistosomiasis mansoni outcome. Exp Parasitol 2007; 115: 324-332.
• 13. Ferreira HS, Coutinho EM. Should nutrition be considered as a supplementary measure in schistosomiasis control? Ann Trop Med Parasitol 1999; 93: 437-447.
• 14. Coutinho EM, Barros AF, Barbosa A Jr, Oliveira SA, Silva LM, Araujo RE, et al. Host nutritional status as a contributory factor to the remodeling of schistosomal hepatic fibrosis. Mem Inst Oswaldo Cruz 2003; 98: 919-925.
• 15. Teixeira CC, Andrade ZA. Hepatic regeneration following partial hepatectomy in mice infected with Schistosoma mansoni. Braz J Med Biol Res 1985; 18: 201-205.
• 16. Cheever AW, Jankovic D, Yap GS, Kullberg MC, Sher A, Wynn TA. Role of cytokines in the formation and downregulation of hepatic circumoval granulomas and hepatic fibrosis in Schistosoma mansoni-infected mice. Mem Inst Oswaldo Cruz 1998; 93 (Suppl 1): 25-32.
• 17. Andrade ZA, Cheever AW. Characterization of the murine model of schistosomal hepatic periportal fibrosis ('pipestem' fibrosis). Int J Exp Pathol 1993; 74: 195-202.
• 18. Michalopoulos GK, DeFrances M. Liver regeneration. Adv Biochem Eng Biotechnol 2005; 93: 101-134.
• 19. Morcos SH, Khayyal MT, Mansour MM, Saleh S, Ishak EA, Girgis NI, et al. Reversal of hepatic fibrosis after praziquantel therapy of murine schistosomiasis. Am J Trop Med Hyg 1985; 34: 314-321.

Correspondence and Footnotes

Publication Dates

• Publication in this collection
  08 Sept 2009
• Date of issue
  Sept 2009

History

• Accepted
  22 June 2009
• Received
  29 Sept 2008